Skip to main content

Advertisement

SpringerLink
Log in

Standardization of in vitro assays to evaluate the activity of polyherbal siddha formulations against Chikungunya virus infection

  • Original article
  • Published:
VirusDisease Aims and scope Submit manuscript

Abstract

Chikungunya, a viral fever caused by Aedes mosquito results in extreme morbidity in affected individuals and is a major public health concern in India. Currently, modern vaccines or formulations prescribed by physicians can only provide symptomatic relief for the pyretic and post pyretic phase of the disease. Siddha practitioners follows strict medical regimen based on traditional Indian knowledge/concepts to treat Chikungunya with considerable results. The current study was undertaken to standardize assays for the study of these siddha formulations and to check their efficacy and potential mode of action as antivirals for Chikungunya virus infection in in vitro system. Although, siddha practitioners follow a regime containing 4–6 formulations, of these Brahmanandha bairavam mathirai, a part of the regime for Chikungunya followed at National Institute of Siddha and Vishnu chakram along with Brahmanandha bairavam mathirai, a part of Thiruchergodu Regime were found of have antiviral activities. It was observed that both Vishnu chakram and Brahmanandha bairavam mathirai were equally effective in blocking Chikungunya virus from entering susceptible cells in the concentrations range of 0.0625 and 0.5 mg/ml. Additionally, it was also observed that Brahmanandha bairavam mathirai was more effective than Vishnu chakram against entry of Chikungunya in the cells. The assays used in this study provides insights to the possible mode of action of various formulations used by siddha practitioners for the treatment of Chikungunya infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952–53. I. Clinical features. Trans R Soc Trop Med Hyg. 1955;49(1):28–32.

    Article  CAS  PubMed  Google Scholar 

  2. Gerardin P, Guernier V, Perrau J, Fianu A, Le Roux K, Grivard P, et al. Estimating Chikungunya prevalence in La Reunion Island outbreak by serosurveys: two methods for two critical times of the epidemic. BMC Infect Dis. 2008;8:99. https://doi.org/10.1186/1471-2334-8-99.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Mavalankar D, Shastri P, Raman P. Chikungunya epidemic in India: a major public-health disaster. Lancet Infect Dis. 2007;7(5):306–7. https://doi.org/10.1016/S1473-3099(07)70091-9.

    Article  PubMed  Google Scholar 

  4. Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, et al. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet. 2007;370(9602):1840–6. https://doi.org/10.1016/S0140-6736(07)61779-6.

    Article  CAS  PubMed  Google Scholar 

  5. Zheng K, Li J, Zhang Q, Liang M, Li C, Lin M, et al. Genetic analysis of chikungunya viruses imported to mainland China in 2008. Virol J. 2010;7:8. https://doi.org/10.1186/1743-422X-7-8.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Volk SM, Chen R, Tsetsarkin KA, Adams AP, Garcia TI, Sall AA, et al. Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates. J Virol. 2010;84(13):6497–504. https://doi.org/10.1128/JVI.01603-09.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Hochedez P, Jaureguiberry S, Debruyne M, Bossi P, Hausfater P, Brucker G, et al. Chikungunya infection in travelers. Emerg Infect Dis. 2006;12(10):1565–7. https://doi.org/10.3201/eid1210.060495.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Miner JJ, Aw-Yeang HX, Fox JM, Taffner S, Malkova ON, Oh ST, et al. Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis. Arthritis Rheumatol. 2015;67(5):1214–20. https://doi.org/10.1002/art.39027.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Jain J, Nayak K, Tanwar N, Gaind R, Gupta B, Shastri JS, et al. Clinical, serological and virological analysis of 572 chikungunya patients during the years 2010–2013 from India. Clin Infect Dis. 2017. https://doi.org/10.1093/cid/cix283.

    Google Scholar 

  10. Brighton SW, Prozesky OW, de la Harpe AL. Chikungunya virus infection. A retrospective study of 107 cases. S Afr Med J. 1983;63(9):313–5.

    CAS  PubMed  Google Scholar 

  11. Staples JE, Breiman RF, Powers AM. Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis. 2009;49(6):942–8.

    Article  PubMed  Google Scholar 

  12. Borgherini G, Poubeau P, Staikowsky F, Lory M, Le Moullec N, Becquart JP, et al. Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis. 2007;44(11):1401–7. https://doi.org/10.1086/517537.

    Article  PubMed  Google Scholar 

  13. Borgherini G, Poubeau P, Jossaume A, Gouix A, Cotte L, Michault A, et al. Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island. Clin Infect Dis. 2008;47(4):469–75. https://doi.org/10.1086/590003.

    Article  PubMed  Google Scholar 

  14. Schilte C, Staikowsky F, Couderc T, Madec Y, Carpentier F, Kassab S, et al. Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis. 2013;7(3):e2137. https://doi.org/10.1371/journal.pntd.0002137.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Jain J, Dubey SK, Shrinet J, Sunil S. Dengue Chikungunya co-infection: a live-in relationship? Biochem Biophys Res Commun. 2017. https://doi.org/10.1016/j.bbrc.2017.02.008.

    Google Scholar 

  16. Thirunarayanan T. An introduction to siddha medicine. Tiruchendur: Thirukumaran Publishers; 1981.

    Google Scholar 

  17. Subbarayappa B. Siddha medicine: an overview. The Lancet. 1997;350(9094):1841.

    Article  CAS  Google Scholar 

  18. Lavekar G, Padhi M. Management of chikungunya through ayurveda and siddha a technical_report. New Delhi: Central Council for Research in Ayurveda and Siddha; 2009.

    Google Scholar 

  19. Lavekar G, Padhi M. Management of chikungunya through ayurveda and siddha: a technical report. New Delhi: Central Council for Research in Ayurveda and Siddha; 2007. p. 28–44.

    Google Scholar 

  20. Anbarasu K, Manisenthil KK, Ramachandran S. Antipyretic, anti-inflammatory and analgesic properties of nilavembu kudineer choornam: a classical preparation used in the treatment of chikungunya fever. Asian Pac J Trop Med. 2011;4(10):819–23.

    Article  CAS  PubMed  Google Scholar 

  21. Murugan R, Vembu T, Kumarswamy M. Toxicological study of a siddha sastric formulation arumuga chendhuram in rat model. J Appl Pharm Sci. 2016;6(3):81–87.

    Article  Google Scholar 

  22. Manickavasakam K. Acute and sub acute toxicity studies on Sarva Noi Linga Chenduram in rodents. Int J Curr Res Chem Pharm Sci. 2017;4(2):13–18.

    Article  Google Scholar 

  23. Ramya Devi D, Sandhya P, Malarvizhi K, Subashri S, Abinaya M, Vedha Hari B. Development of ayurvedic and siddha medicine through the application of modern pharmaceutical technique. Curr Trends Biotechnol Pharm. 673

  24. Shrinet J, Jain S, Sharma A, Singh SS, Mathur K, Rana V, et al. Genetic characterization of Chikungunya virus from New Delhi reveal emergence of a new molecular signature in Indian isolates. Virol J. 2012;9(1):100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Lemm JA, Durbin RK, Stollar V, Rice CM. Mutations which alter the level or structure of nsP4 can affect the efficiency of Sindbis virus replication in a host-dependent manner. J Virol. 1990;64(6):3001–11.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Sourisseau M, Schilte C, Casartelli N, Trouillet C, Guivel-Benhassine F, Rudnicka D, et al. Characterization of reemerging chikungunya virus. PLoS Pathog. 2007;3(6):e89. https://doi.org/10.1371/journal.ppat.0030089.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Kaur P, Thiruchelvan M, Lee RC, Chen H, Chen KC, Ng ML, et al. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression. Antimicrob Agents Chemother. 2013;57(1):155–67. https://doi.org/10.1128/AAC.01467-12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We are thankful to Dr. Sathya Rajeshwaran, Siddha Central Research Institute, Chennai, for his inputs regarding approved siddha regimes. We acknowledge Dr. Vimal Narayanan’s assistance in the preparation of supplementary table. Financial support for the study was received from the Ministry of Ayush, (Grant No: ND/AYU/15/019), Government of India and their support is duly acknowledged.

Author information

Authors and Affiliations

  1. Vector Borne Disease Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India

    Jaspreet Jain & Sujatha Sunil

  2. Department Virology and Immunology, Amity University, Noida, Uttar Pradesh, India

    Somnath Pai

Authors
  1. Jaspreet Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Somnath Pai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sujatha Sunil
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sujatha Sunil.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 19 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jain, J., Pai, S. & Sunil, S. Standardization of in vitro assays to evaluate the activity of polyherbal siddha formulations against Chikungunya virus infection. VirusDis. 29, 32–39 (2018). https://doi.org/10.1007/s13337-018-0421-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13337-018-0421-0

Keywords

Search

Navigation